Resource Listing
Allarta Life Science
Cell Technology
Allarta Life Science
Founded in 2019
About
Allarta Life Science is a pre-clinical regenerative medicine company with a proprietary allogeneic cell delivery platform to enable cell-based, curative therapies for chronic endocrine disorders such as Diabetes, Hemophilia and Lysosomal Storage Disorders, without the need for immune suppression.
McMaster Founder
Harald Stover (Faculty of Science).
Fusion Pharmaceuticals
Cancer and Drug Discovery
Fusion Pharmaceuticals
Founded in 2014
About
Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on becoming the leader in the Targeted Alpha Therapy field. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre headquartered at McMaster University. Their Targeted Alpha Therapy has the potential to be used across multiple tumor types including colorectal, bladder, lung cancer and more.
McMaster Founder
John Valliant (Faculty of Science).
Naturally Synthetic
Biotechnology
Naturally Synthetic
Founded in 2021
About
Naturally Synthetic aims to realize the full potential of a new synthetic chemistry technology. Many plant-derived molecules can be made available in large quantities and high purity. This opens the door to their clinical testing and potential approval as medicines or nutraceuticals to improve human health and wellbeing.
McMaster Founder
Jakob Magolan (Faculty of Science).
Q-Reserve
Data Analysis and Software
Q-Reserve
Founded in 2014
About
QReserve helps organizations with complex scheduling workflows to automate and optimize their processes through a powerful online web platform, integrations, and expert support.
McMaster Contributors
John Brennan, Fred Capretta and Brandon Aubie (Faculty of Science).
Synth-Med Biotechnology
Drug Delivery
Synth-Med Biotechnology
Founded in 2020
About
Synth-Med Biotechnology makes blood smart by producing functional red blood cells as part of a proprietary platform that delivers drugs to specific targets of 3 main areas: erythrocyte-based nutraceuticals, functionalized erythrocytes for the delivery of cancer vaccines, and delivering neurotrophic factor across the blood-brain barrier.
McMaster Founders
Maikel Rheinstadter and Sebastian Himbert (Faculty of Science).